Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2000
08/08/2000US6099864 In situ activation of microcapsules
08/08/2000US6099863 Spray drying mixture
08/08/2000US6099862 Oral dosage form for the controlled release of a biguanide and sulfonylurea
08/08/2000US6099860 Tablets; antiinflammatory agent and decongestant
08/08/2000US6099859 Controlled release oral tablet having a unitary core
08/08/2000US6099858 Using blend of gelatin and glucose
08/08/2000US6099857 Cell membrane fusion composition and method
08/08/2000US6099856 Increased bioavailable
08/08/2000US6099853 Vaccine containing deactivated bacteria
08/08/2000US6099835 Method of using antiviral composition
08/08/2000US6099829 Comprising cross-linked, water-swellable polymers, where the oil phase consists of one or more fatty acid esters
08/08/2000US6099562 Drug coating with topcoat
08/08/2000US6099556 Method of controlling exothermic reaction of an exothermic composition, the exothermic composition, an exothermic device and an application pad
08/08/2000US6099517 Intrapulmonary delivery of polypeptide growth factors and cytokines
08/08/2000US6098615 Method of reproducibly effecting a patient's glucose level
08/08/2000CA2212309C Extended-release solid oral dosage forms of drugs having low solubility in water
08/08/2000CA2138270C Prosthetic devices having enhanced osteogenic properties
08/08/2000CA2125904C Controlled release formulations coated with aqueous dispersions of ethylcellulose
08/08/2000CA2097695C Biological stain composition, method of preparation and method of use for delineation of epithelial cancer
08/08/2000CA2087341C Bone growth stimulator
08/08/2000CA2056653C Preparation for transdermal drug administration
08/08/2000CA2030670C Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound
08/08/2000CA1341077C Luminide and macroluminide class of pharmaceuticals
08/05/2000CA2267049A1 Pharmaceutical compositions
08/04/2000CA2261278A1 Injectable and/or drinkable nose and mouth spray
08/03/2000WO2000045167A2 Non-invasive method for detecting target rna
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044895A1 Method and medicament for inhibiting the expression of a defined gene
08/03/2000WO2000044863A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof
08/03/2000WO2000044846A1 Adhesives
08/03/2000WO2000044808A1 Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups
08/03/2000WO2000044757A1 Hesperitin pro-forms with enhanced bioavailability
08/03/2000WO2000044744A1 Potassium salt of ($i(s))-omeprazole
08/03/2000WO2000044682A1 Biodegradable glass compositions and methods for radiation therapy
08/03/2000WO2000044681A2 Method for preparing porous shells or gels from glass particles
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044406A2 Dna vaccines against hantavirus infections
08/03/2000WO2000044398A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000WO2000044396A1 Use of nerve growth factor for therapy of intraocular tissue pathologies
08/03/2000WO2000044393A2 Buccal delivery system for proteinaceous medicaments
08/03/2000WO2000044389A2 Method for preparing membrane vesicles
08/03/2000WO2000044386A1 Method for treatment of headache
08/03/2000WO2000044380A1 Release-regulating preparations
08/03/2000WO2000044369A1 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
08/03/2000WO2000044367A2 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/03/2000WO2000044366A2 Therapeutic compositions containing glutathione analogs
08/03/2000WO2000044356A1 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
08/03/2000WO2000044355A1 Moxonidine salts
08/03/2000WO2000044354A1 Lyophilisates with improved reconstitutibility
08/03/2000WO2000044353A1 Pharmaceutical compositions
08/03/2000WO2000044352A1 Method of preparing particles for agglomeration
08/03/2000WO2000044351A1 Fast dispersing dosage forms free of gelatin
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000044349A1 Non-invasive vaccination through the skin
08/03/2000WO2000044348A2 Materials and methods for making improved micelle compositions
08/03/2000WO2000044347A1 Medicated stick composition
08/03/2000WO2000044342A1 Galenic formulation containing biotin
08/03/2000WO2000044333A2 Novel injectable antimalarial compositions of artemisinin
08/03/2000WO2000037062A3 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
08/03/2000WO2000030605A3 Method for producing medicaments from plant extracts, in a solid form of administration
08/03/2000WO2000025824A3 Stable preparations with hyperforin
08/03/2000WO2000024382A3 Method for producing solid spherical materials containing a biologically active substance
08/03/2000WO2000023065A3 Storable active substance concentrate with formoterol
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000WO2000020609A3 Protective recombinant haemophilus influenzae high molecular weight proteins
08/03/2000WO2000013476B1 A bubble drop and method of making same
08/03/2000WO2000010533A9 Compositions and methods for treating intracellular infections
08/03/2000WO2000004876A9 Controlled release of bioactive substances
08/03/2000WO1999059638A8 Compositions and methods for the delivery of nucleic acid molecules
08/03/2000DE19903275A1 Lyophilisate mit verbesserter Rekonstituierbarkeit Lyophilisates with improved reconstitutability
08/03/2000DE19903241A1 Galenische Formulierung Drug formulation
08/03/2000DE19852928C1 Strukturen in Form von Hohlkugeln Structures in the form of hollow spheres
08/03/2000CA2730386A1 Formulations comprising antisense nucleotides to connexins
08/03/2000CA2361268A1 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/03/2000CA2361262A1 Buccal delivery system for proteinaceous medicaments
08/03/2000CA2361260A1 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000CA2360997A1 Non-invasive method for detecting target rna
08/03/2000CA2360752A1 Method for preparing membrane vesicles
08/03/2000CA2360686A1 Release-regulating preparations
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2360195A1 Adhesives
08/03/2000CA2359317A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000CA2358967A1 Hesperitin pro-forms with enhanced bioavailability
08/03/2000CA2325887A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof
08/02/2000EP1024401A2 Alkaline soluble mixture composed of cellulose derivatives
08/02/2000EP1023908A2 Medical composition of hydroxy acid-based oligomer
08/02/2000EP1023904A2 Adjuvants for use in vaccines
08/02/2000EP1023899A1 Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
08/02/2000EP1023896A2 Opioid formulations for treating pain
08/02/2000EP1023895A2 Base for suppository
08/02/2000EP1023842A2 Edible powder material having excellent shelf stability
08/02/2000EP1023445A1 Cadherin derived growth factor and the application thereof
08/02/2000EP1023440A1 Enteric coated microgranules for stabilizing lactic acid bacteria
08/02/2000EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules
08/02/2000EP1023103A1 Fluid delivery device with temperature controlled energy source
08/02/2000EP1023083A1 Veterinary vaccines
08/02/2000EP1023082A1 Tumour vaccine
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023077A1 Opthalmic composition
1 ... 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 2481 ... 2991